Article
Riboflavin status, MTHFR genotype and blood pressure: current evidence and implications for personalised nutrition.
The Proceedings of the Nutrition Society - 1 Aug 2016
McAuley E, McNulty H, Hughes C, Strain J J, Ward M
Abstract excerpt
Clinical deficiency of the B-vitamin riboflavin (vitamin B2) is largely confined to developing countries; however accumulating evidence indicates that suboptimal riboflavin status is a widespread problem across the developed world. Few international data are available on riboflavin status as measured by the functional biomarker, erythrocyte glutathione reductase activation coefficient, considered to be the gold...
Topics
- Animals
- Biomarkers
- Blood Pressure
- Dietary Supplements
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Folic Acid
- Genotype
- Homozygote
- Humans
- Ireland
- Methylenetetrahydrofolate Reductase (NADPH2)
- Nutritional Requirements
- Nutritional Status